Spire Wealth Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
Spire Wealth Management's FLGT Position: Q1 2025 in Review
Spire Wealth Management sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 285 shares — an estimated $5.26K sold.
Spire Wealth Management first reported a position in FLGT in Q1 2021 and held it in 16 quarters. The position peaked at $138K in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.
- Spire Wealth Management reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
- Spire Wealth Management sold 285 Fulgent Genetics shares in Q1 2025, an estimated $5.26K.
- Spire Wealth Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 16 quarters.
- Spire Wealth Management's Fulgent Genetics position peaked at $138K in Q4 2021.
- 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.
Based on Spire Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.